Articles tagged with Peptides
Researchers analyzed over 1.5 million SARS-CoV-2 genome sequences to understand the evolution of the virus, finding that increased infectivity is a driving force behind its spread. The omicron variant is predicted to compromise current vaccines and therapies, highlighting the need for new generation of vaccines and monoclonal antibodies.
A research team led by Dr. Serge Krasnokutski has discovered a reaction pathway that can form peptide chains under cosmic conditions without water. This finding suggests that the origin of peptides could be extraterrestrial in nature, challenging the conventional assumption that life emerged on Earth.
A new study published in Nature Communications found that amylin peptide plays a crucial role in regulating social contact-seeking behavior in female mice. The researchers discovered that isolation leads to a decrease in amylin levels, while social reunion increases them.
Scientists from Japan and USA develop a microfluidic device for purification of tuberculosis genomic DNA fragments, enabling accurate diagnosis of diseases. The device uses transient ITP and electrokinetic trapping to detect and purify small cfDNA fragments.
A new generation of cholesterol-lowering drugs is being developed to target the PCSK9 protein, which regulates LDL receptor degradation on cells. These therapies have shown promise in reducing LDL levels with fewer side effects than statins.
Researchers at the University of Oklahoma have developed a molecular framework that solves the challenge of predicting peptide structures. The framework bridges experimental and computer sciences, enabling the use of machine learning and artificial intelligence to model peptide structures for materials engineering.
Researchers at Rice University and Baylor College of Medicine have created an antibody with an engineered peptide that effectively targets and attacks bone tumors in breast cancer. The study shows the therapeutic efficacy is best when a moderate amount of the drug compound is delivered, offering new hope for treating bone metastases.
Scientists have discovered a new layer of regulation in plant-microbe interactions using peanut studies. An antisense long-noncoding RNA, DONE40, was found to bind to a protein involved in epigenetic control, suggesting a conserved function across plants and animals.
Researchers identified 40 peptide pairs with potential cross-reactivity between BCG vaccination and SARS-CoV-2, offering a new strategy to complement existing COVID-19 vaccines. These peptides can induce T cell responses and INF-γ production, providing long-lasting immunity against viral infections.
Researchers at MUSC identified a potent antifibrotic peptide that reverses scarring in human and mouse tissues by activating an antifibrotic pathway. The E4 peptide has the potential to treat various diseases, including heart disease, lung fibrosis, liver cirrhosis, and chronic kidney disease.
Researchers have created a powerful DNA-peptide hybrid that could lead to advancements in nanotechnology and the study of Alzheimer's disease. The new structure combines three-stranded DNA and peptide structures, overcoming the challenge of chirality between these biomolecules.
Scientists developed a breakthrough fabrication process for microneedle arrays capable of administering protein-based drugs without damaging the skin. The microneedles offer several advantages, including being painless and easy to dispose of.
A new study reveals that flexibility in peptides used to treat Type 2 diabetes may be key to their effectiveness. The research found that a peptide called GLP-1 can switch between two shapes, maximizing its potency and activating insulin release from the pancreas.
Scientists at Kumamoto University have developed a novel peptide vaccine that improves obesity-related dyslipidemia and may be cost-effective. The vaccine targets angiopoietin-like protein 3 (ANGPTL3) and has been shown to reduce dyslipidemia in mice, producing antibodies that last for six months.
Researchers at the University of Bath have optimised a peptide that prevents alpha-synuclein misfolding, a key feature of Parkinson's disease. The new molecule, 4654W(N6A), has shown significant promise in lab experiments and could lead to the development of a disease-modifying treatment.
Researchers at the University of Oklahoma have discovered a new protein fragment that could improve cartilage regeneration and reduce the need for osteoarthritis treatments. The protein fragment, developed by Handan Acar and Amgad Haleem, aims to help the body heal itself by elicititing a response from stem cells.
Researchers at USC developed a new peptide that stimulates the host's immune response to fight bacterial infections, offering an alternative to antibiotics. The peptide, MTD12813, is highly effective in clearing infections and modulates inflammation, reducing the risk of complications.
A team of researchers has extracted and analyzed ancient proteins and DNA from nearly 4,000 bone fragments at Denisova Cave, yielding five human bones with intact biomolecules, dating back to 200,000 years ago. The findings provide robust insights into the first occupants of the cave and their archaeological signature.
A new type of PRRT, <sup> 177 </sup> Lu-DOTA-LM3, has been shown to be safe and effective in treating neuroendocrine neoplasms. The therapy achieved complete remission in some patients and was well-tolerated by most patients.
Scientists at Tokyo Institute of Technology developed a new peptide sensor to detect and quantify water-soluble synthetic polymers in wastewater. The technique uses machine learning algorithm to identify and discriminate between different polymers.
Researchers develop a technique to scan and sequence single proteins, one amino acid at a time, using nanopore DNA sequencing technology. This breakthrough opens the way for single-molecule protein sequencing and cataloguing proteins inside a single cell.
Researchers at Children's Hospital of Philadelphia have developed a novel therapy that targets proteins essential for tumor growth and survival. Using a multi-omics approach, they identified peptides unique to neuroblastoma tumors, which are then targeted by peptide-centric chimeric antigen receptors (PC-CARs).
Researchers at the University of Waterloo have created a deep neural network that detects disease biomarkers with high accuracy, achieving 98 per cent detection of peptide features. This breakthrough could enable earlier and more accurate disease detection through tissue sample analysis.
Researchers have identified a gene called Nup54 that plays a crucial role in regulating female reproductive behaviors in fruit flies. This discovery provides new insights into the molecular mechanisms underlying sexual conflict and its impact on evolution.
Scientists have identified specific peptides in milk that relieve stress and enhance sleep. The study found that one of these peptides, YPVEPF, increased sleep duration by over 400% in mice.
Researchers at TTUHSC have identified novel targets for treating stroke, focusing on enhancing neurolysin activity. The study discovered small molecules that can selectively enhance the activity of neurolysin, which showed promise in reducing damage to the brain after a stroke.
A peptide-drug conjugate called CBX-12 has been shown to enhance the efficacy of immune checkpoint inhibitors in preclinical cancer models by targeting the acidic environment of cancer cells. The treatment exhibited significantly delayed tumor growth, improved survival, and complete tumor regressions compared to immunotherapy alone.
Researchers at Uppsala University have designed new antibodies that bind to both large and small aggregates of the amyloid-beta protein, potentially providing a more effective treatment for Alzheimer's disease. The new antibody format is stronger in binding to clumps and can also target smaller aggregates.
Scientists use specific self-assembling peptides to organize silica nanoparticles into larger structures, demonstrating a new approach to self-assembly. The researchers' method enables the creation of novel materials with various applications, including drug delivery systems and nanocatalysts.
A new study found that a subtilisin-like proteinase from Bacillus pumilus 3-19 exhibits proteolytic activity in Pichia pastoris, dependent on incubation time and signal peptide choice. The production of this enzyme makes the system promising for developing new feed additives for animal husbandry.
Researchers designed novel molecules that bound tightly to SARS-CoV-2's molecular scissors, inhibiting the virus's replication. The breakthrough could lead to new treatments for COVID-19.
A new biomimetic system mimics the body's own receptors for anesthetics, providing prolonged nerve blockade with minimal toxicity. The system consists of nanostructures that bind to tetrodotoxin and slowly release it, allowing for long-lasting pain relief without systemic toxicity.
Researchers found that certain peptides associated with migraine pain can regulate insulin production in mice, potentially preventing type 2 diabetes. The study suggests that these peptides could be developed into therapeutic strategies to control blood sugar levels, while minimizing the risk of migraines.
Researchers from ETU LETI and Institute of Highly Pure Biopreparations proposed a new-generation biochip for multiparametric express-testing using molecular recognition and direct fluorimetry. The device selectively detects cardiac markers without fluorescent labels, reducing background fluorescence to 30%.
Scientists have developed stable peptide mimics called peptoids to treat viruses and prevent infections. Peptoids, such as those tested against SARS-CoV-2 and HSV-1, could one day cure or prevent many kinds of infections, including COVID-19.
Researchers at Virginia Tech have developed a scalable method to harvest exosomes from unpasteurized cow's milk, enabling the production of purified exosomes for oral drug delivery. The new protocol advances pharmaceutical applications for fragile drugs and opens up a wide range of clinical applications.
Researchers assessed effectiveness of T-cell immune response to 11 SARS-CoV-2 variants, identifying HLA gene variants with significantly changed virus peptides. The T-cell COVID-19 Atlas portal (T-CoV) provides a comprehensive resource for understanding the impact of viral mutations on immunity.
Researchers developed gel drops from four amino acid peptides that support cell growth and induce blood vessel formation. The microgels were successfully used to grow endothelial cells on their surfaces, which then extended into tubular blood vessels.
Researchers have developed a neural network model called BiteNetPp to detect protein-peptide binding sites, enabling the design of peptide-based drugs. The model consistently outperforms existing methods and can analyze a single protein structure in under a second, making it suitable for large-scale studies.
Researchers at Imperial College London have created a metal-based molecule that inhibits the build-up of amyloid-β peptides associated with Alzheimer's disease. The molecule was shown to be non-toxic to human brain-like cells and cross the blood-brain barrier in mice using focused ultrasound.
Researchers discovered that physical load stimulates bone growth through the expression of osteocrin (OSTN), a peptide produced by osteoblasts. OSTN is critical to regulating bone growth and physical endurance, with its expression decreasing when load is reduced and increasing with load stimulation.
Scientists at Tokyo Institute of Technology developed a computational method to predict the cell-membrane permeability of cyclic peptides, exhibiting promising accuracy. The protocol has potential to aid in designing and discovering cyclic peptide drugs with high cell-membrane permeability.
The new MaxDIA software provides a computational workflow for data-independent acquisition proteomics, combining library-based and library-free approaches. This enables highly sensitive and accurate data analysis for thousands of proteins, opening up new possibilities for medical applications in personalized medicine.
Researchers develop a de novo peptide Y15 that readily forms secondary structures to enable bottom-up synthesis of functional protein assemblies in live cells. The peptide enables the formation of fibrous structures and clusters in test tubes and live cells, facilitating protein assembly and reconstitution of natural complexes.
Scientists at the University of Tennessee Institute of Agriculture are working on developing biobased peptides to restrict ice crystal growth in freezing temperatures. Successful methods could improve frozen food quality, increase crop resistance to freezing temperatures, and enhance biomedical research.
A human endogenous peptide called LL-37 has been identified as a powerful blocker of toxic α-synuclein oligomers, which are responsible for neurodegeneration in Parkinson's disease. The discovery suggests that this naturally occurring molecule could be a safe and effective therapy to slow down the progression of the disease.
Researchers have developed a novel synthesis method using peptides to create green gold nanoparticles, which can target and destroy cancer cells using near-infrared light. The findings provide an easy and eco-friendly protocol for Au nanoparticle synthesis, opening doors to non-toxic nanoparticle therapeutic agents.
A naturally occurring peptide in sunflower seeds has been identified as a potential drug for treating abdominal pain or inflammation. The peptide selectively activates pain transmission pathways without causing opioid side effects, reducing the risk of dependency and overdose.
A team of researchers from the University of Queensland has discovered a venomous caterpillar that produces peptides with high potency against nematode parasites and disease-causing pathogens. The study also unlocks a source of bioactive peptides with potential uses in medicine, biotechnology, and scientific tools.
Researchers at King Abdullah University of Science & Technology (KAUST) create a biomaterial that supports the growth of bone marrow precursor cells and forms tubular blood vessels, mimicking natural bone tissue architecture. This breakthrough enables the development of 3D disease models for tissue engineering and biomedical research.
Researchers have determined how peptides derived from PEDF protect neuronal cells in the retina layer, which could lead to treatments for degenerative retinal diseases such as age-related macular degeneration. The study found that these peptides work by binding to a protein receptor and processing omega-3 fatty acids like DHA.
Researchers developed a cell-penetrating peptide to prevent septic shock in animal models. The treatment shows promise in protecting patients with metabolic syndrome and those at risk of severe COVID-19 complications.
Researchers at the University of Göttingen have developed a non-toxic method to label peptides and investigate their mechanism of action. The new technique allows for efficient screening of molecules important for the adaptive immune system, which can help fight infections and cancer.
Researchers at Kazan Federal University and Chinese Academy Sciences have developed peptide nanoparticles that can be visualized in living cells using hyperspectral microscopy. These nanoparticles have the ability to scatter light efficiently, allowing for non-fluorescent labeling of cells.
A research team identified the structure of hetero-oligomers causing Alzheimer's and Parkinson's diseases to overlap. The study reveals that these aggregates have more degrees of freedom, allowing peptides to be loosely packed on their surface.
Researchers have developed new peptide markers to identify African bovid species, enabling more accurate analysis of ancient animal remains. The discovery sheds light on subsistence strategies and paleoenvironments in Iron Age Zambia.
MUSC researchers develop peptide siRNA carriers that improve gene silencing and deliver siRNA into cancer cells. The modified carriers, such as RD3AD, use filopodia entry to efficiently deliver the therapeutic molecules.
A Stanford bioengineer has developed peptide-like molecules called peptoids that can retain therapeutic properties against viruses, offering a new approach to treating infectious diseases. The peptoids work by disrupting the virus's outer membrane, making them promising antiviral agents.
A team of scientists from Pompeu Fabra University has developed a peptide that allows delta-9-tetrahydrocannabinol (THC) to fight pain in mice without cognitive side effects. The peptide, which interrupts the interaction between THC and serotonin receptors, improves memory capacity while providing analgesia.
Researchers have developed a bicyclic peptide that binds to and inhibits the oncogenic protein beta-catenin, which is associated with certain types of tumor. The peptide's unique hairpin shape and cyclic nature mimic natural protein structures, making it an attractive starting point for developing new antitumor drugs.